839 related articles for article (PubMed ID: 18097455)
41. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
Grunberg SM
Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744
[TBL] [Abstract][Full Text] [Related]
42. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
Hesketh PJ
Oncologist; 1999; 4(3):191-6. PubMed ID: 10394587
[TBL] [Abstract][Full Text] [Related]
43. Comparative activity of antiemetic drugs.
Jordan K; Schmoll HJ; Aapro MS
Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
[TBL] [Abstract][Full Text] [Related]
44. [Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting].
Tavernier J; Jouannet-Romaszko M; Bertucat H; Marchiset N; Bahadoor M; Chevrier R
Bull Cancer; 2016; 103(7-8):622-31. PubMed ID: 27178880
[TBL] [Abstract][Full Text] [Related]
45. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
Gralla R
Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
[No Abstract] [Full Text] [Related]
46. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
Prommer E
J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609
[TBL] [Abstract][Full Text] [Related]
47. [Antiemetics and its clinical evaluations].
Furue H
Gan To Kagaku Ryoho; 1992 Mar; 19(3):294-301. PubMed ID: 1543357
[TBL] [Abstract][Full Text] [Related]
48. Antiemetic drugs.
Cranwell-Bruce L
Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
[No Abstract] [Full Text] [Related]
49. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
50. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
Yamaguchi M; Ogawa T; Watanabe M; Anami S; Kamigaki S; Nishikawa N; Ono T; Furukawa H
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1691-6. PubMed ID: 19838029
[TBL] [Abstract][Full Text] [Related]
51. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
Oo TH; Hesketh PJ
Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
[TBL] [Abstract][Full Text] [Related]
52. Control of chemotherapy-induced emesis.
Grunberg SM; Hesketh PJ
N Engl J Med; 1993 Dec; 329(24):1790-6. PubMed ID: 8232489
[TBL] [Abstract][Full Text] [Related]
53. [An antiemetic guideline for patients with malignancies in Japan].
Takeuchi H; Saeki T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):976-979. PubMed ID: 20567095
[TBL] [Abstract][Full Text] [Related]
54. Antiemetic therapy in patients receiving cancer chemotherapy.
Marek C
Oncol Nurs Forum; 2003; 30(2):259-71. PubMed ID: 12692660
[TBL] [Abstract][Full Text] [Related]
55. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
Kris MG; Hesketh PJ; Herrstedt J; Rittenberg C; Einhorn LH; Grunberg S; Koeller J; Olver I; Borjeson S; Ballatori E
Support Care Cancer; 2005 Feb; 13(2):85-96. PubMed ID: 15565277
[TBL] [Abstract][Full Text] [Related]
56. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Hartvig P
J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570
[No Abstract] [Full Text] [Related]
57. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting.
Cope D
Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282
[No Abstract] [Full Text] [Related]
58. [ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment].
Longo F; Mansueto G
Tumori; 2005; 91(1):suppl 36-48. PubMed ID: 15850022
[No Abstract] [Full Text] [Related]
59. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
60. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
Sarcev T; Secen N; Zaric B; Milovancev A
J BUON; 2008; 13(3):333-9. PubMed ID: 18979546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
